21 November 2017
News and Views
Links and Services
A study in June's issue of the Inflammatory Bowel Diseases investigates the effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease.
Since immunomodulators and antitumor necrosis factor (TNF) agents are increasingly used to treat
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors